It’s been 1 year and 36 days since Starpharma announced a commercial settlement with Mundipharma via the ASX.
Shareholders were told in the announcement that Starpharma was now ‘free to engage with healthcare companies’ and was ‘well positioned to sign new commercial arrangements’, and importantly, with commercial interest having ‘already been expressed’
Yet here we are into the 2nd year of trying to find a distribution partner whilst the product and commercial opportunity withers on a vine.
It’s the same old Starpharma. They talk game but can never bring it.
Where’s the Mundipharma replacement?
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $38.39M | |||
| Open | High | Low | Value | Volume |
| 9.2¢ | 9.3¢ | 9.1¢ | $210.6K | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 467139 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 152000 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |